Navigation Links
Biotech Leaders Wei-Wu He, Ph.D and Tak W. Mak, Ph.D Join EntreMed's Board of Directors
Date:2/6/2012

ROCKVILLE, Md., Feb. 6, 2012 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that Wei-Wu He, Ph.D has joined the Board of Directors as Executive Chairman and Tak W. Mak, Ph.D has joined as a member of the Board of Directors.

(Logo: http://photos.prnewswire.com/prnh/20010620/ENMDLOGO )

Dr. Wei-Wu He is currently the CEO and Chairman of OriGene Technologies, Inc. He also is the founder and General Partner of Emerging Technology Partners, LLC (ETP), a life sciences focused venture fund established in Maryland since 2000. Dr. He was also one of the first few employees at Human Genome Sciences, Inc. and from 1993 to 1996 was a scientist at the company.  Prior to that he was a Research Fellow at Massachusetts General Hospital and Mayo Clinic. Dr. He has been involved in founding and funding over 20 biotech companies throughout his career.  Dr. He received his Ph.D. from Baylor College of Medicine and MBA from The Wharton School of University of Pennsylvania.  Dr. He is an author to more than 25 research publications and inventor of over 30 issued patents.  

Dr. Tak W. Mak is currently the Director of the Campbell Family Institute for Breast Cancer Research at the Princess Margaret Hospital and a University Professor in the Department of Medical Biophysics and Department of Immunology, University of Toronto.  He was trained at the University of Wisconsin in Madison, the University of Alberta and the Ontario Cancer Institute.  He is best known as the leading scientist of the group that first cloned the genes of the human T cell antigen receptor.  Dr. Mak is an Officer of the Order of Canada, and has been elected a Foreign Associate of the National Academy
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. European Pharmaceutical and Biotech Contract Manufacturing Markets
2. Biotechnology Pharmaceutical Company Selects NewCardios QTinno for Thorough QT Trial
3. Leaders of Healthcare, Biotech and Pharmaceutical Companies Sending Proclamation to President Obama and Congress Urging Solution to Nations Healthcare Crisis
4. Aethlon Medical Discloses Availability of the Biotech Showcase™ 2012 Presentation
5. Lixte Biotechnology Holdings Announces Issuance of U.S. Patent for Agents for the Treatment of Neurodegenerative Diseases
6. GenturaDx to Present at the Biotech Showcase Conference
7. Inovio Pharmaceuticals to Present at Biotech Showcase Investor Conference
8. Trinity Biotech to Present at Sidoti & Companys Semiannual New York Micro-Cap Conference on January 9, 2012
9. Aethlon Medical Announces Biotech Showcase™ 2012 Presentation
10. Ikaria® to Present at Biotech Showcase™ 2012
11. Express Scripts HealthBridge Pharma & Biotech to Provide Specialty Pharmacy and Specialty Distribution Services for EYLEA™ (aflibercept) Injection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... 2015 Global physiotherapy ... USD 24.7 billion by 2022, according to a ... prevalence of neurological and musculoskeletal disorders are expected ... forecast period. The presence of efficient and effective ... the technologies coupled with implementation of favorable government ...
(Date:8/3/2015)... (NASDAQ: CYTR ), a biopharmaceutical research and development ... the three months ended June 30, 2015, and also ... for its clinical development programs. "The second ... Enrollment in our ongoing pivotal global Phase 3 clinical ... on track to be completed in the first quarter ...
(Date:8/3/2015)... Aug. 3, 2015 Merrimack Pharmaceuticals, Inc. (Nasdaq: ... its Second Quarter 2015 Investor Conference Call and webcast ... The call will cover an update on Merrimack,s ... 2015 financials. A press release detailing the information to ... afternoon of Monday, August 10. Investors and the general ...
Breaking Medicine Technology:Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 2Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 3Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 4Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 5CytRx Reports 2015 Second Quarter Financial Results 2CytRx Reports 2015 Second Quarter Financial Results 3CytRx Reports 2015 Second Quarter Financial Results 4CytRx Reports 2015 Second Quarter Financial Results 5CytRx Reports 2015 Second Quarter Financial Results 6CytRx Reports 2015 Second Quarter Financial Results 7CytRx Reports 2015 Second Quarter Financial Results 8CytRx Reports 2015 Second Quarter Financial Results 9CytRx Reports 2015 Second Quarter Financial Results 10CytRx Reports 2015 Second Quarter Financial Results 11CytRx Reports 2015 Second Quarter Financial Results 12CytRx Reports 2015 Second Quarter Financial Results 13CytRx Reports 2015 Second Quarter Financial Results 14Merrimack Pharmaceuticals Announces Timing of Second Quarter 2015 Investor Conference Call 2
... (OTCQB: SCLR) announced today that it has launched several ... drug delivery platform, Controlled Delivery Technology ... under various private label brands across the country at ... product has been designed to deliver the full nutritional ...
... Feb. 16, 2012   Remedy Informatics, the leading provider ... Translational research, announced that its Founder and CEO, Gary ... R&D Informatics and Knowledge Management Track on Tuesday, Feb. ... 22 at Molecular Med TRI-CON Feb. 19-23, 2012, in ...
Cached Medicine Technology:SCOLR Pharma, Inc. Launches Cutting Edge Nutritional Products at Major Retailers in 2012 2Remedy Informatics CEO, Gary Kennedy, to Speak at Molecular Med TRI-CON 2Remedy Informatics CEO, Gary Kennedy, to Speak at Molecular Med TRI-CON 3
(Date:8/3/2015)... ... August 03, 2015 , ... ... to Seattle-based Genelex to offer pharmacogenetic lab testing and precision medicine solutions that ... care costs. , Annually, more than 8.6 million adverse drug events are ...
(Date:8/3/2015)... ... August 03, 2015 , ... Dental practice in ... patients in need. Most people know that general health emergencies, such as broken arms ... amount of people know where to turn to during a dental emergency. This is ...
(Date:8/3/2015)... Florida (PRWEB) , ... August 03, 2015 , ... ... for Physician Leadership ® and Navigant Center for Healthcare Research and Policy Analysis ... , Fifty-five percent of respondents said they agreed or strongly agreed that the ...
(Date:8/3/2015)... ... , ... The U.S. Food and Drug Administration (FDA) recently approved a new ... which occurs naturally in the body and helps absorb and breakdown fat cells. Previously, ... body. These are invasive procedures and very expensive for most people. Now with Kybella, ...
(Date:8/3/2015)... ... ... Illinois Health & Science (IHS) has completed the purchase of IBA Molecular ... IBAM NA’s cyclotron sites and research and development facilities. , “We are ... as a large manufacturing hub in Noblesville, Indiana,” said Ken Smithmier, President and CEO ...
Breaking Medicine News(10 mins):Health News:Novation Awards Genelex First Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software 2Health News:Novation Awards Genelex First Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software 3Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 2Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 3Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 2Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 3Health News:Dr. Ava Shamban to Offer the New Double Chin Treatment Kybella 2Health News:Dr. Ava Shamban to Offer the New Double Chin Treatment Kybella 3Health News:Illinois Health & Science Expands Nuclear Medicine Footprint With Purchase of IBA Molecular North America, Inc. 2
... researchers from Stanford have identified the nitric oxide gas as ... resulting in the development of an embryo.He says,it begins with ... ,The research is based on the sex lives of ... in the Pacific Ocean just a few yards from Epel's ...
... flowing smoothly after angioplasty shows surprising success in early testing. ... the drug-coated stent. //In testing on 50 patients over 3 ... ,More than 2 million Americans undergo angioplasty annually, ... most of them if these promising results hold up in ...
... in arresting the dental plaque bacteria believed to be ... report at the American Association// for Dental Research annual ... produces hydrogen peroxide is the key to the antimicrobial ... associate professor of biochemistry at the University of Waikato, ...
... Scientists form Johns Hopkins University School of Medicine have recently ... in the brain that lets us stop smelling something, even ... in a recent issue of the journal Science show that ... receptor cells.The main job of these neurons is to detect ...
... Corp is close to signing a deal to acquire the ... fellow US drugmaker Abbott Laboratories Inc. An industry source who ... in the next few days to buy the stake in ... senior Abbott officials from the company’s regional office in singapore ...
... undergoing open heart surgery for patients in their mid-eighties ... and advisable for the elderly.// ,According to Dr. ... University ,open heart surgery, if indicated, is safe and ... and head of cardiac surgery at Southeastern Healthcare in ...
Cached Medicine News:Health News:The route to fertilization, 2Health News:Heart Surgery Is Getting Safer for the Old 2
... Oxygen Conservation Device. Bypass ... ,6200 Accessories: , OCD870C ... CGA 540 Regulator , OCD2001-18 ... Booklet , CP2140 Vertical M-6 ...
... Catheter with Accutrol is similar in design ... that it incorporates a temperature probe at ... temperature probe can accurately determine the patient's ... provides temperature accuracy comparable to a pulmonary ...
... These markers are available with 16 or 24 ... 6.5mm diameter, and an outer 9.5mm diameter. The markers ... in one single step for a 16 or 24 ... outer points on the cornea to achieve a precise ...
... Through A 1.0mm Incision., ,Special Direct Acting ... Improved ... Approach., ,Recessed Jaws For Improved Sub-Incisional Flap ... Jaws During Sterilization., ,Reusable, Autoclaveable, Guaranteed For ...
Medicine Products: